Cell-Based Assays (2011)

What is this event about?

About the conference: Now that the majority of screening assays employ the use of cell-based technologies, robust cell-based assays are essential for lead identification and the optimization of therapeutic candidates. Factors including the ever-increasing numbers of compound failures and rapidly escalating costs of R&D are driving the uptake of increasingly biologically relevant surrogates in cell-based assays to predict the response of drug candidates; leading to developments in areas including stem cell use in screening programmes, 3D cell cultures and label-free detection. These technologies, and the effective techniques and methods employed in their use have been progressing at breakneck speed and this conference will assemble leading experts from both industry and academia to present you with the latest updates, technologies and critical strategies in a practical, case-study focused environment. Cell-Based Assays is the place for senior scientists from assay development, pharmacology, screening and related fields to meet and discuss progress in the area and exchange ideas moving forward. A dual focus on both strategic and regulatory concerns, alongside more specific scientific and technical analysis, supported with extensive case studies, ensures a truly comprehensive treatment of the most important issues.     The event will consist of a two-day conference and a post-conference workshop, with a focus on a range of topics relating to the challenges facing those involved in using and developing cell-based assays and their importance to the strategic future of R&D in pharma.   Why not attend the associated workshop as well? Associated with the conference there will be a one day workshop taking place on 23rd November Led by leaders in their field, our workshops are an excellent opportunity to explore in a more intimate and interactive setting issues which will be discussed at the conference.  Fancy speaking at the conference?  Do you know of anyone who may be interested in speaking?  We are always on the look-out for new speakers for our upcoming conferences.  Let us know - contact the Producer. For sponsorship and exhibitioning opportunities, contact our Sponsorship Department.

 How you will benefit

• Hear about new techniques, technologies and methods used in cell-based assays
• Discuss the use of stem cells in discovery and development
• Explore the powers of RNAi screening in target discovery and biomarker identification
• Learn from multiple case studies demonstrating real life data and processes that work
• Network with key industry associates and solution providers to share valuable experiences

Sponsored by:

Confirmed speakers include:

Simon T. Barry, Associate Director, Oncology iMED, AstraZeneca

Firas Bassissi, Senior Scientist/Lab Manager, Preclinical Candidate Selection Unit, Abbott

Nathan Bays, Research Fellow and Team Lead, High Throughput Flow Cytometry and Cell Biology, Merck & Co

Brigitte Boldyreff,  European Agent,  Carna Biosciences 

Davide Danovi, Research Associate, Cancer Unit, University College London

Laura DeForge, Senior Scientist, Assay & Automation Technology, Genentech

Marie-Cecile Didiot, Post-Doctoral Researcher, Novartis Pharmaceuticals

Roy Edward, Sales & Marketing Director, Biostatus Ltd

Alexandra Fuchs, COO, CYTOO Cell Architects

Cedric Gaggioli, Research Fellow, INSERM

Anker Jon Hansen, Principal Scientist, Novo Nordisk

Rodolphe Hajj, Division of Molecular Pharmacology and Pathophysiology, Servier Research Institute, France, speaking on behalf of BD Biosciences - Cell Analysis

Stefan Kostense, Director, Clinical Assays, Crucell

Steven Ludbrook, Cellular Section Head, GSK

Katharina Maniura, Co-Head, Laboratory for Materials-Biology Interactions, EMPA

Corinne Ploix, Head of Assay Development and Qualification Immunosafety, Roche

Stefan Przyborski, Director & CSO, Reinnervate and Professor of Cell Technology, University of Durham

Peter Simpson, Associate Director, Assay Sciences Group, AstraZeneca

Andrew Southan, Head, Ion Channel Pharmacology, Biofocus

Glyn Stacey, Director of the UK Stem Cell Bank, NIBSC/HPA

Pamela Tranter, Group Head, Automated Electrophysiology, Novartis

Daniel Zicha, Head of Light Microscopy, Cancer Research UK

Who should attend this event?

Heads of Department, Directors, Managers, Team Leaders Researchers and Scientists from: Screening  Pre-clinical Research  Pharmacology  Lead discovery technologies  Molecular and cellular biology  Biological technologies  Lead generation and optimization  High-content analysis  Target identification and validation  Target discovery  In vitro assays  Compound profiling  Assay development

Delegates at our 2010 Cell-Based Assay conference came from across the world... Join the wide range of high-level delegates at our event in 2011..

 Previous attendees and participants have come from organizations including: 

GSK Pfizer MedImmune Genzyme Cancer Research UK  Imperial College London  Actelion Pharmaceuticals  Essen BioScience  BD Biofocus PLC

Novartis Sanofi Aventis Merck Sharp & Dohme UCB Pharma  The Netherlands Cancer Institute University of Bonn John Hopkins University  Prosidion  Ablynx Enzo Life Science

Roche Diagnostics  Genentech Boehringer Ingelheim Unilever European Molecular Biology Laboratory University of Dundee  Maxcyte  Epic System  Advancell Cyntellect Biostatus Ltd

AstraZeneca Bayer Schering Pharma Lilly Research Centre L'oreal EMPA NIBSC Leiden University  Odyssey Thera  Lonza Asterand UK

Novo Nordisk Takeda San Diego Merck Chemicals  Medical Research Council for Immune Regulation Stem Cell Sciences University of Birmingham  Corning Life Sciences Fluofarma Griffin Life Science Celentyx